[
  {
    "ts": null,
    "headline": "Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness",
    "summary": "If you are wondering whether Danaher is priced fairly today, or if the current share price leaves some value on the table, this article is for you. The stock last closed at US$209.94, with returns of 0.2% over 7 days, a 6.5% decline over 30 days, an 8.9% decline year to date, and a 1.7% gain over 1 year, set against a 5 year return of 10.9% and a 3 year return of a 5.0% decline. Recent interest in Danaher has been shaped by ongoing coverage of its position in the pharmaceuticals and biotech...",
    "url": "https://finnhub.io/api/news?id=aa44dd27af24ca4a67996de5d7baeaae7d974c9d7eea9f82fa85f75d59e50d58",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772244819,
      "headline": "Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness",
      "id": 139259623,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "If you are wondering whether Danaher is priced fairly today, or if the current share price leaves some value on the table, this article is for you. The stock last closed at US$209.94, with returns of 0.2% over 7 days, a 6.5% decline over 30 days, an 8.9% decline year to date, and a 1.7% gain over 1 year, set against a 5 year return of 10.9% and a 3 year return of a 5.0% decline. Recent interest in Danaher has been shaped by ongoing coverage of its position in the pharmaceuticals and biotech...",
      "url": "https://finnhub.io/api/news?id=aa44dd27af24ca4a67996de5d7baeaae7d974c9d7eea9f82fa85f75d59e50d58"
    }
  }
]